Generic Pharmaceuticals Company for Sale in Nalagarh, India

- Operates a pharmaceutical manufacturing company producing a wide range of formulations for domestic and international markets.
- Manufactures injectables (50% of revenue), tablets and capsules (30%), and liquids and ointments (20%).
-The Company’s manufacturing plant was until recently fully operational and contributed to its historical operating performance. Following the introduction of new Government norms, the Company undertook a regulatory-driven restructuring to ensure compliance. The restructuring, initially expected to take 2–3 months, took approximately 7 months due to its scope and complexity, resulting in a 4–5 month delay. The plant subsequently resumed production and operated for approximately 3 months before a capital crunch, arising from the prolonged restructuring period and associated compliance costs, strained working capital. Consequently, the plant has remained non-operational for the last 2 months. The shutdown is due to working capital constraints and regulatory restructuring, and not due to any issue with demand, product quality, or market standing.
- Supplies products to hospitals, distributors, and pharmaceutical marketers across India and 40+ export markets.
- Maintains a strong portfolio of over 1,400 registered products with an additional pipeline of approximately 1,300 products.
- Generates around 40% of revenue from exports, reflecting established global market presence.
- Equipped with certified manufacturing facilities compliant with GMP and ISO standards.
- Backed by over two decades of operational experience in pharmaceutical manufacturing.
- Operates scalable infrastructure with capacity for expansion and increased production.
- Does not require USFDA approval for its current operations and target markets.
- Registered with the Ministry of Corporate Affairs (MCA) and holds valid GST certification.